ETON 250117 2.50P (ETON250117P2500) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

ETON250117P2500

Watchlist

0.00
0.000.00%

15min DelayClose Jan 2 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Eton Pharmaceuticals Acquires Galzin For Terms Undisclosed, Expands Rare Disease Treatment Portfolio
Benzinga10minutes ago
Express News | Eton Pharmaceuticals Inc - to Commercialize Galzin in U.S. in Q1 2025
Reuters13minutes ago
Eton Pharmaceuticals Advances Its Commitment To Rare Disease With The Acquisition Of Galzin(R) >ETON
Dow Jones13minutes ago
Express News | Eton Pharmaceuticals Advances Its Commitment to Rare Disease With the Acquisition of Galzin®
Reuters13minutes ago
Craig-Hallum Initiates Eton Pharmaceutical(ETON.US) With Buy Rating
Moomoo NewsDec 20, 2024 14:31 ET · Ratings
Eton Pharmaceuticals Closes Acquisition Of Increlex(R) (Mecasermin Injection) >ETON
Dow JonesDec 20, 2024 06:50 ET

Comments

Trytosaveabit

Dec 20, 2024 05:51

Update

$Eton Pharmaceutical (ETON.US)$ Reuters
just
Eton Pharmaceuticals Closes Acquisition of Increlex® (Mecasermin Injection)

Trytosaveabit

Dec 17, 2024 05:57

Update

$Eton Pharmaceutical (ETON.US)$ Eton Pharmaceuticals Announced The Full Readout From The Clinical Trial Evaluating PKU GOLIKE As A Protein Substitute For Phenylketonuria In Patients During Prolonged Fasting Periods
Benzinga· 5 mins ago1min
The study demonstrated that PKU GOLIKE, administered as the last daily dose and compared to standard amino acid protein substitutes, improved metabolic control by reducing harmful phenylalanine (Phe) levels and increasing beneficial tyrosine (Tyr) levels,...

Jaguar8

Nov 25, 2024 05:54

NEWS

$Eton Pharmaceutical (ETON.US)$
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)
Eton Pharmaceuticals has acquired U.S. rights to Amglidia (glyburide oral suspension) from AMMTeK for treating neonatal diabetes mellitus.
The product, already approved by the European Medicines Agency since 2018, has received Orphan Drug Designation from the FDA. Amglidia is a patented liquid formulation targeting approximately 300 U.S. patients with neonatal dia...

Trytosaveabit

Nov 25, 2024 05:53

Update

$Eton Pharmaceutical (ETON.US)$ Reuters· 2 mins ago
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)

Trytosaveabit

Oct 8, 2024 17:43

New form 4

$Eton Pharmaceutical (ETON.US)$